A detailed history of Sandy Spring Bank transactions in Sanofi stock. As of the latest transaction made, Sandy Spring Bank holds 63 shares of SNY stock, worth $3,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 63 -0.0%
Holding current value
$3,631
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$50.95 - $55.2 $3,209 - $3,477
63 New
63 $3,000
Q1 2023

May 05, 2023

BUY
$45.86 - $54.45 $11,281 - $13,394
246 New
246 $13,000
Q4 2021

Feb 11, 2022

SELL
$47.07 - $52.35 $9,414 - $10,470
-200 Closed
0 $0
Q3 2021

Nov 05, 2021

SELL
$47.89 - $53.12 $9,578 - $10,624
-200 Reduced 50.0%
200 $10,000
Q2 2021

Aug 09, 2021

BUY
$49.36 - $54.25 $19,744 - $21,700
400 New
400 $21,000
Q1 2021

May 03, 2021

SELL
$45.46 - $50.51 $2,818 - $3,131
-62 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$42.91 - $52.5 $2,617 - $3,202
-61 Reduced 49.59%
62 $3,000
Q1 2020

May 01, 2020

BUY
$38.02 - $51.66 $950 - $1,291
25 Added 25.51%
123 $6,000
Q4 2019

Feb 06, 2020

BUY
$44.25 - $50.86 $4,336 - $4,984
98 New
98 $5,000
Q1 2019

May 06, 2019

SELL
$40.83 - $45.43 $175,609 - $195,394
-4,301 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$41.48 - $45.59 $51,435 - $56,531
-1,240 Reduced 22.38%
4,301 $187,000
Q2 2018

Aug 03, 2018

SELL
$37.63 - $41.22 $6,585 - $7,213
-175 Reduced 3.06%
5,541 $222,000
Q1 2018

May 04, 2018

BUY
$38.98 - $45.76 $151,320 - $177,640
3,882 Added 211.67%
5,716 $229,000
Q4 2017

Feb 02, 2018

SELL
$42.86 - $50.61 $5,443 - $6,427
-127 Reduced 6.48%
1,834 $79,000
Q3 2017

Nov 03, 2017

BUY
$47.04 - $50.34 $25,213 - $26,982
536 Added 37.61%
1,961 $98,000
Q2 2017

Aug 11, 2017

BUY
N/A
1,425
1,425 $68,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $145B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.